User login
Enter your username and password here in order to log in on the website:
Please note: While some information will still be current in a year, other information may already be out of date in three months time. If you are in any doubt, please feel free to ask.
MEVEOL® studies
- Question
- Hello
Few times ago I discovered the MEVEOL® program, performed by the pharmaceutical company ALAXIA. One publication has been done in 2009.
On the ALAXIA’s web site we can noticed that:
“ - MEVEOL® is a “candidate drug” effective for treating respiratory infection in cystic fibrosis
- scientists from ALAXIA have proved, with the help of recognized experts, its antimicrobial effectiveness on different strains including methicillin-resistant Staphylococcus aureus (MRSA), Burkholderia cepacia and Pseudomonas aeruginosa”.
This drug seems interesting….But has the program advanced? Do you have more information?
Thank you.
Best regards. A patient.
- Answer
- Hello
We haven’t any new information regarding MEVEOL®’s development.
Best regards,
Anna Ronayette
- 03.05.2013
- Please find more information under:
ecorn-cf.eu/index.php?id=65&L=0&tx_expertadvice_pi1%5Bshowitem%5D=1920&tx_expertadvice_pi1%5Bsearch%5D=MEVEOL
ecorn-cf.eu/index.php?id=65&L=0&tx_expertadvice_pi1%5Bshowitem%5D=1219&tx_expertadvice_pi1%5Bsearch%5D=MEVEOL
D. d'Alquen
